Literature DB >> 29673810

A systematic review of emerging respiratory viruses at the Hajj and possible coinfection with Streptococcus pneumoniae.

Jaffar A Al-Tawfiq1, Samir Benkouiten2, Ziad A Memish3.   

Abstract

BACKGROUND: The annual Hajj to the Kingdom of Saudi Arabia attracts millions of pilgrims from around the world. International health community's attention goes towards this mass gathering and the possibility of the development of any respiratory tract infections due to the high risk of acquisition of respiratory viruses.
METHOD: We searched MEDLINE/PubMed and Scopus databases for relevant papers describing the prevalence of respiratory viruses among Hajj pilgrims.
RESULTS: The retrieved articles were summarized based on the methodology of testing for these viruses. A total of 31 studies were included in the quantitative/qualitative analyses. The main methods used for the diagnosis of most common respiratory viruses were polymerase chain reaction (PCR), culture and enzyme-linked immunosorbent assay (ELISA). Influenza, rhinovirus and parainfluenza were the most common viruses detected among pilgrims. Coronaviruses other than MERS-CoV were also detected among pilgrims. The acquisition of MERS-CoV remains very limited and systematic screening of pilgrims showed no infections.
CONCLUSIONS: Well conducted multinational follow-up studies using the same methodology of testing are necessary for accurate surveillance of respiratory viral infections among Hajj pilgrims. Post-Hajj cohort studies would further evaluate the impact of the Hajj on the acquisition of respiratory viruses.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Hajj; Mass gatherings; Respiratory viruses; Saudi Arabia; Streptococcus pneumonia

Mesh:

Year:  2018        PMID: 29673810      PMCID: PMC7110954          DOI: 10.1016/j.tmaid.2018.04.007

Source DB:  PubMed          Journal:  Travel Med Infect Dis        ISSN: 1477-8939            Impact factor:   6.211


Introduction

Religious events and festivals are types of mass gathering that draw large numbers of pilgrims from a large geographical region and people around the globe [1,2]. The annual Hajj pilgrimage to Makkah in the Kingdom of Saudi Arabia (KSA) attracts more than 2 million pilgrims from 184 countries around the world [1]. The climatic conditions and the inevitable overcrowding of pilgrims in Makkah and surrounding holy sites during the Hajj rituals create a situation that may promote the occurrence and spread of communicable diseases and possibly the spread of multi-drug resistance (MDR) bacteria [1,[3], [4], [5], [6], [7], [8], [9]]. Thus, the spread of respiratory illnesses during the Hajj is a major public health concerns with the potential of dissemination of these infectious diseases beyond the Hajj itself [[10], [11], [12]]. Risk factors for such an event to occur include close proximity between pilgrims, crowded accommodation, and congregation [1,6]. Studies had shown that respiratory tract infections occur commonly among the majority of pilgrims [10,13]. Also, it is estimated that more than 90% of pilgrims develop what is known as the “Hajj cough” during their stay in KSA [[14], [15], [16]]. Many studies showed that a variety of upper and lower respiratory tract infections due to viral and bacterial infections can cause infections among pilgrims [[3], [4], [5],10,[17], [18], [19], [20], [21]]. A range of respiratory viruses were recovered from pilgrims, with influenza and rhinovirus the most common [10]. In this review, we summarize the available data about emerging respiratory viruses, including Middle East Respiratory Syndrome Coronavirus (MERS-CoV), Severe Acute Respiratory Syndrome (SARS), and other respiratory viruses such as influenza. We also discuss here the possible role of Streptococcus pneumoniae coinfection.

Search strategy

We searched MEDLINE and Scopus databases for articles published in English using the following search strategy: #1: “hadj” OR “hajj” OR “pilgrimage”; #2: “respiratory”; #3: “viral” OR “virus” OR “viruses” OR “pathogens” OR “infection” OR “infections”; #4: “influenza”; #5: “Middle East Respiratory Syndrome Coronavirus” OR “MERS-CoV”; #6: “Severe Acute Respiratory Syndrome” OR “SARS”; #7: “Pandemic H1N1”; #8: #1 AND #2 AND #3 AND #4 AND #5 AND #6 AND #7. We also hand searched the Saudi Epidemiology Bulletin (available at: http://www.fetp.edu.sa/Bulletin.html) for additional articles for inclusion. The search results were surveyed for methodological articles, and their titles and abstracts were then scanned. Additional studies were identified through bibliographies of original articles or relevant reviews. The search was done according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines [22]. One author (JAT) performed the searches, screened titles/abstracts for eligibility, selected relevant papers and reviewed each of the selected manuscripts in full. All authors were in agreement regarding the choice of papers.

Results

Included studies

The search strategy initially yielded 365 records of which 71 were duplicates. Twenty additional papers were identified through hand searching. Of the 104 full text articles reviewed, 31 studies were included in the final analysis. The results of the search strategy are shown in Fig. 1 according to the PRISMA methodology [22].
Fig. 1

Flow diagram of the search strategy.

Flow diagram of the search strategy.

Types of included studies

The included studies were classified based on the methods used to detect respiratory viruses. Methods include polymerase chain reaction (PCR) [15,[23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42]] (Table 1 ), cell culture [26,27,[43], [44], [45]] (Table 2 ), direct immunofluorescence staining [46], and enzyme-linked immunosorbent assay (ELISA) [[47], [48], [49]] (Table 3 ).
Table 1

A Summary of Studies addressing the Prevalence of Respiratory Viruses among Pilgrims using PCR Methods, data presented as percentage of the total number of included pilgrims in each study.

Reference[23][24][25][26][27][28][29][30][31][32][33][34][35][36][37][38][38][15][39][39][40][41][42][54]
Number of Included Pilgrims20255511025527580112387551305269948416008391691291296924703840847300125
Influenza A-H1N10.51.80.9001.60.13.50.500.80.71.636.73
Influenza A-H3N29.92.93.628.615.606.26.221.72.64.3
Influenza A (all)10.48.28.14.76.34.515.828.612.60.39.17.51.36.93.64.79.37.27.33
Influenza B3.52.32.37.30.15.41.30.80.700.23.53.33.62
Influenza overall13.910.510.4126.34.515.828.610.514.581.37.87.63.69.61310.510.95
RSV4.50.40.25.10.80.70.21
Parainfluenza 1000.900001
Parainfluenza 2000000.30.40
Parainfluenza 30.41.31.8000.10.22
Parainfluenza overall0.41.32.72.600.80.50.60
Rhinovirus9.25.948.826.839.526.614.734.430.9
Entero-rhino virus20012.916.82.347
CoV-229E7.80.212.414.610.26
CoV-NL6300.10.820.23
CoV-HKU100.13.91.31.50
CoV-OC432.60.53.91.61.93
CoV overall2.710.40.92119.513.812
Metapneumovirus00.10.80.10.6
Table 2

A Summary of Studies addressing the Prevalence of Respiratory Viruses among Pilgrims using Cell Culture, data presented as percentage of the total number of included pilgrims in each study.

Reference[43][44][49][26][27]
Study DesignCross-sectional study (Saudi Arabia)Cross-sectional study (Saudi Arabia)Cross-sectional study (Saudi Arabia)Cross-sectional airport study (Iran)Cross-sectional airport study (Iran)
Number of Included Pilgrims761500105225275
Influenza A4.50.61.95.1
H1N11.1
Influenza B25.411.45.1
Influenza overall6.5613.35.11.1
Parainfluenza 12
Parainfluenza 21.7
Parainfluenza 32.2
Parainfluenza overall5.90.80
Adenovirus4.7036.2
Respiratory syncytial virus2.41.41.9
Herpes virus2.6
Table 3

A Summary of Studies addressing the Prevalence of Respiratory Viruses among Pilgrims using Direct Immunofluorescence Staining or ELISA, data presented as percentage of the total number of included pilgrims in each study.

Reference[46][47][48][49]
MethodologyDirect immunofluorescence stainingELISAELISAELISA
Year1994200020042004–5
Number of Included Pilgrims64305360105
Influenza A3.15.9
H1N16.9
H3N26.1
Influenza B1.611.520.8
Influenza overall4.717.412.8
Parainfluenza 10
Parainfluenza 21.6
Parainfluenza 30
Parainfluenza overall1.6
A Summary of Studies addressing the Prevalence of Respiratory Viruses among Pilgrims using PCR Methods, data presented as percentage of the total number of included pilgrims in each study. A Summary of Studies addressing the Prevalence of Respiratory Viruses among Pilgrims using Cell Culture, data presented as percentage of the total number of included pilgrims in each study. A Summary of Studies addressing the Prevalence of Respiratory Viruses among Pilgrims using Direct Immunofluorescence Staining or ELISA, data presented as percentage of the total number of included pilgrims in each study.

Study designs

The included studies were cross-sectional studies, case-control studies, and prospective cohort studies. These studies had different designs and methodology, and varied widely in terms of the number of included pilgrims. We included studies addressing the prevalence of viral respiratory infections. Many of these studies reported the prevalence of clinical respiratory tract infections among pilgrims, including upper respiratory tract infection (URTI), acute respiratory infection (ARI) or influenza-like illness (ILI) [16,28,38,40,[50], [51], [52], [53]]. We included in the analysis studies addressing microbiology and laboratory diagnosis of viral respiratory infections based on culture, ELISA or PCR methods.

Studies based on polymerase chain reaction methods

Included studies that used PCR methods for the detection of the respiratory viruses are summarized in Table 1 [15,[23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42], [54],54]. The overall analysis of these studies shows the most common viruses detected among pilgrims (Fig. 2 ), including influenza (A and B) virus (7.1%), influenza A (5.1%), rhinovirus (5.1%), and influenza B (1.9%). These studies did not screen for the same surveyed viruses and there was a large variation in the screened viruses (see Fig. 2).
Fig. 2

A summary of studies among pilgrims showing the most common respiratory viruses using PCR based techniques.

A summary of studies among pilgrims showing the most common respiratory viruses using PCR based techniques.

Studies based on culture methods

A number of studies have detected respiratory viruses among pilgrims using culture methods (Table 2). These studies included a total of 1866 pilgrims, and the most common viruses detected among them are shown in Fig. 3.
Fig. 3

A Summary of Studies among Pilgrims Showing the Most Common Respiratory Viruses Using Culture based Methods.

A Summary of Studies among Pilgrims Showing the Most Common Respiratory Viruses Using Culture based Methods.

Other studies using alternative methods for the detection of respiratory viruses

Other studies, using alternative methods for the detection of respiratory viruses, have detected respiratory viruses (primarily influenza viruses) among pilgrims. ELISA was used in three studies [[47], [48], [49]] and direct immunofluorescence staining was used in one study [46]. A summary of the findings of these studies are presented in Table 3.

2009 pandemic influenza A (H1N1) and the Hajj

It was feared that the 2009 pandemic influenza A (H1N1) would result in a significant impact on the Hajj [55,56], especially that 200,000 pilgrims in 2008 were from resource-limited countries [56]. In total, six studies investigated the prevalence of H1N1 virus among pilgrims [27,[32], [33], [34], [36],36] and one study was conducted among healthcare workers at the pilgrimage sites [57] (Table 4 ). During the 2009 Hajj season, the prevalence of H1N1 virus among 275 symptomatic Iranian pilgrims was 1.8% [27]. However, none of the 184 screened healthcare workers was infected [57]. A large cross sectional study of 2699 departing pilgrims showed that 0.1% of them were positive for H1N1 virus [34]. Two other studies have also founded prevalence of 1.6% [33] and 1.8% [27], but none of the 551 Egyptian pilgrims survived in another study were positive for H1N1 virus [32].
Table 4

A Summary of Studies addressing the Prevalence of Pandemic H1N1 Influenza among Pilgrims.

ReferenceStudy DesignPopulationNumber Testedn (%) Positive
[27]cross sectionalReturning Iranian pilgrims2755 (1.8)
[32]cross sectionalReturning Egyptian pilgrims5510 (0)
[33]cross sectionalReturning Iranian pilgrims3055 (1.6)
[34]cross sectionalDeparting pilgrims26992 (0.1)
[36]cross sectionalPilgrims16009 (0.5)
[57]cross sectionalHealthcare workers1840 (0)
A Summary of Studies addressing the Prevalence of Pandemic H1N1 Influenza among Pilgrims.

Threat of emerging coronaviruses

In the last decade, two coronaviruses emerged, the SARS-CoV in 2003 and the MERS-CoV in 2012. Coronavirus infections were detected in 0.6–0.8% of tested population in regard to the Hajj seasons [3]. There were no cases of SARS linked to the Hajj [58].

Systematic screening for MERS-CoV among attendees of the annual Hajj

Despite the 2012 Hajj season started few weeks after the first case of MERS-CoV infection was reported, there were no reported cases among pilgrims in 2012 [5,25,32]. Systematic screening of pilgrims for MERS-CoV was done in multiple studies among >10,000 pilgrims [5,14,29,31,35,[37], [38], [39], [41], [42], [54], [59], [60], [61], [62], [63],41,42,54,[59], [60], [61], [62], [63]] (Table 5 ).
Table 5

Systematic screening of MERS-CoV among pilgrims.

ReferenceYear of the studyStudy populationMethodNumber ScreenedN (%) positive
[5]2012Symptomatic FrenchNasopharyngeal swab3000
[14]2012French cohortNasopharyngeal swab1540
[15]2013Departing PilgrimsNasal swabs1290
[29]2013Pilgrims from Saudi Arabia, Australia and QatarNasal swabs10380
[30]2013Admitted Pilgrims with PneumoniaSputum380
[31]2014Symptomatic pilgrims returning to AustriaSputum, throat swab, or bronchoalveolar lavage70
[35]2012–2015EgyptianNasopharyngeal and oropharyngeal swabs4840
[37]2013Adult African Hajj pilgrims returning to Ghana, West AfricaNasopharyngeal swab8390
[39]2013Departing Pilgrims, paired and non-paired cohortNasal swabs692 (paired cohort),514 (non-paired arriving cohorts);and 470 (non-paired departing cohort)0
[38] [15]2013French pilgrimsNasal and throat swab1290
[60]2013Multiple nationalitiesNasopharyngeal swab3210 pre-Hajj0
[60]2013Multiple nationalitiesNasopharyngeal swab2025 post-Hajj0
[61]2013–2015Symptomatic British PilgrimsUpper and lower respiratory tract2020
[63]2013–15Ill French travelersNot indicated330
[41]2013–2015ChineseLower respiratory tract sputum, washes, and upper respiratory tract oropharyngeal swab8470
[54]2015JordanianNasopharyngeal and oropharyngeal1250
[42]2014–2015Kashmir, north Indianasopharyngeal and throat swabs3000
Systematic screening of MERS-CoV among pilgrims.

Coinfection of respiratory viruses and S. pneumoniae

In a recent study conducted among 129 French pilgrims in 2013, about 39% of those who tested positive for S. pneumoniae after the Hajj pilgrimage were co-infected with at least one virus [38]. However, there is no information on whether the pilgrims were carrying S. pneumoniae or were ill secondary to this organism.

Discussion

The most common viruses were rhinovirus, influenza A and coronavirus 229E. In addition, the acquisition of MERS-CoV remains very limited and systematic screening of pilgrims showed no infections. MERS-CoV is absent in all Hajj pilgrims tested so far. Different methods were used for the diagnosis of respiratory pathogens and included: PCR, culture methods and ELISA. The ease and rapidity of PCR method make this method an attractive method for further use in subsequent studies to detect respiratory viruses. Interestingly, it appears that some viruses are more prone to transmission during Hajj (influenza and Rhinoviruses). The difference in the transmission could be related to a predominant aerial transmission for Influenza and Rhinoviruses whereas other (less prevalent) could rely on direct contact (hands carry-over). Camels were not allowed in the Hajj areas due to the risk of MERS-CoV transmission and this strategy may further decrease the risk of MERS-CoV transmission. Different respiratory viruses might be acquired during the Hajj and these viruses might be introduced into pilgrims' home countries upon their return, thus contributing to the potential for international spread of these viruses. Preventing influenza transmission during Hajj is an important target for public health. Influenza vaccination should be a priority for all Hajj pilgrims [64]. Vaccination is not so easy due to regulation on seasonal vaccine availability [65]. In addition, non-pharmacological preventive measures are needed for the prevention of respiratory infections during the Hajj: maintaining good infection control practice among healthcare workers, the use of face masks or respirators, and hand hygiene [66,67]. The majority of viral respiratory infections acquired during pilgrimage are due to influenza viruses, and rhinoviruses [64]. The diagnosis of seasonal influenza during the hajj was a major focus of most studies addressing the prevalence of respiratory viruses among pilgrims [23,25,[32], [33], [34], [36], [39], [40], [43], [56], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79], [80],36,39,40,43,56,[68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79], [80]]. In these studies, different methods were used to detect respiratory viruses, with PCR being the most common used method. There are multiple contributing factors for the transmission and acquisition of respiratory viruses during the Hajj and include the crowdedness, close proximity, and indoor or outdoor venue [80]. Consistent with few studies worldwide, entero-rhinovirus was the most common virus isolated among pilgrims. However, this result is related to a single study of 2699 departing pilgrims that showed a 13% acquisition rate [34]. It was shown that entero-rhinovirus the primary cause of common colds [81,82]. With the emergence of the pandemic 2009 H1N1, there was a fear of the significant impact on the Hajj [55,56]. However, different studies showed very low rate of acquisition of this virus during the 2009 Hajj. Also, the emergence of SARS-CoV and MERS-CoV was of major concerns for mass gatherings such as the Hajj [2,5]. However, to date neither SARS-CoV nor MERS-CoV was found to be transmitted among pilgrims. Systematic screening for MERS-COV among returning or departing pilgrims showed no positive cases [5,14,15,[29], [30], [31], [35], [37], [38], [39], [60], [61], [63],35,[37], [38], [39], [60], [61], [63],60,61,63]. However, four cases were linked to Umrah (also known as the lesser pilgrimage) [69,[83], [84], [85], [86]]. It was estimated that the risk MERS-CoV transmission among pilgrims could be 1–7 cases per Hajj season and 3–10 per Umrah per year [87]. Various studies showed different acquisition rates of respiratory viruses, but only one study showed coinfection with S. pneumoniae. Recent studies showed a significant acquisition of S. pneumoniae and Hemophilus influenzae by returning pilgrims [3,10,12,66,88]. Viral respiratory tract infections, mainly rhinovirus, influenza A and coronavirus 229E, are of major concern during the Hajj. Despite extensive systematic screening, MERS-CoV had not been isolated from pilgrims. Continued surveillance for MERS-CoV is needed to ensure timely detection of any possible imported MERS cases [8,9,64]. Differential transmission of different viruses may play a role in the observed frequencies. Understanding these factors facilitate the development of preventive measures. Further paired prospective studies using a systematic evaluation of pilgrims for these viruses are needed in order to estimate the total burden of viral respiratory diseases during the Hajj. International collaboration would foster evidence-based practices and guidelines for implementation during mass gathering events [10].

Funding

None.

Conflicts of interest

The authors have no conflicts of interest to declare.
  79 in total

1.  Travel-related influenza A/H1N1 infection at a rock festival in Hungary: one virus may hide another one.

Authors:  Elizabeth Botelho-Nevers; Philippe Gautret; Lucas Benarous; Rémi Charrel; Peter Felkai; Philippe Parola
Journal:  J Travel Med       Date:  2010 May-Jun       Impact factor: 8.490

Review 2.  Establishment of public health security in Saudi Arabia for the 2009 Hajj in response to pandemic influenza A H1N1.

Authors:  Z A Memish; S J N McNabb; F Mahoney; F Alrabiah; N Marano; Q A Ahmed; J Mahjour; R A Hajjeh; P Formenty; F H Harmanci; H El Bushra; T M Uyeki; M Nunn; N Isla; M Barbeschi
Journal:  Lancet       Date:  2009-11-14       Impact factor: 79.321

3.  Mass Gatherings and the Spread of Respiratory Infections. Lessons from the Hajj.

Authors:  Jaffar A Al-Tawfiq; Philippe Gautret; Samir Benkouiten; Ziad A Memish
Journal:  Ann Am Thorac Soc       Date:  2016-06

Review 4.  Emergence of drug resistant bacteria at the Hajj: A systematic review.

Authors:  Thongpan Leangapichart; Jean-Marc Rolain; Ziad A Memish; Jaffar A Al-Tawfiq; Philippe Gautret
Journal:  Travel Med Infect Dis       Date:  2017-06-24       Impact factor: 6.211

5.  Severe sepsis and septic shock at the Hajj: etiologies and outcomes.

Authors:  Salim Baharoon; Hamdan Al-Jahdali; Jamal Al Hashmi; Ziad A Memish; Qanta A Ahmed
Journal:  Travel Med Infect Dis       Date:  2008-10-23       Impact factor: 6.211

6.  Tuberculosis is the commonest cause of pneumonia requiring hospitalization during Hajj (pilgrimage to Makkah).

Authors:  A Alzeer; A Mashlah; N Fakim; N Al-Sugair; M Al-Hedaithy; S Al-Majed; G Jamjoom
Journal:  J Infect       Date:  1998-05       Impact factor: 6.072

7.  The impact of mass gatherings and holiday traveling on the course of an influenza pandemic: a computational model.

Authors:  Pengyi Shi; Pinar Keskinocak; Julie L Swann; Bruce Y Lee
Journal:  BMC Public Health       Date:  2010-12-21       Impact factor: 3.295

8.  Travel-related MERS-CoV cases: an assessment of exposures and risk factors in a group of Dutch travellers returning from the Kingdom of Saudi Arabia, May 2014.

Authors:  Ewout B Fanoy; Marianne Ab van der Sande; Marleen Kraaij-Dirkzwager; Kees Dirksen; Marcel Jonges; Wim van der Hoek; Marion Pg Koopmans; Douwe van der Werf; Gerard Sonder; Charlie van der Weijden; Jet van der Heuvel; Luc Gelinck; Jolande W Bouwhuis; Arianne B van Gageldonk-Lafeber
Journal:  Emerg Themes Epidemiol       Date:  2014-10-17

9.  Circulation of respiratory viruses among pilgrims during the 2012 Hajj pilgrimage.

Authors:  Samir Benkouiten; Rémi Charrel; Khadidja Belhouchat; Tassadit Drali; Nicolas Salez; Antoine Nougairede; Christine Zandotti; Ziad A Memish; Malak al Masri; Catherine Gaillard; Philippe Parola; Philippe Brouqui; Philippe Gautret
Journal:  Clin Infect Dis       Date:  2013-07-09       Impact factor: 9.079

10.  Viral respiratory infections among Hajj pilgrims in 2013.

Authors:  Osamah Barasheed; Harunor Rashid; Mohammad Alfelali; Mohamed Tashani; Mohammad Azeem; Hamid Bokhary; Nadeen Kalantan; Jamil Samkari; Leon Heron; Jen Kok; Janette Taylor; Haitham El Bashir; Ziad A Memish; Elizabeth Haworth; Edward C Holmes; Dominic E Dwyer; Atif Asghar; Robert Booy
Journal:  Virol Sin       Date:  2014-11-14       Impact factor: 4.327

View more
  16 in total

1.  Epidemiological and genetic characterization of pH1N1 and H3N2 influenza viruses circulated in MENA region during 2009-2017.

Authors:  Hebah A Al Khatib; Asmaa A Al Thani; Imed Gallouzi; Hadi M Yassine
Journal:  BMC Infect Dis       Date:  2019-04-11       Impact factor: 3.090

2.  Evaluation of the rate, pattern and appropriateness of antibiotic prescription in a cohort of pilgrims suffering from upper respiratory tract infection during the 2018 Hajj season.

Authors:  Hamid Bokhary; Hajj Research Team; Osamah Barasheed; Hala B Othman; Burhanudin Saha; Harunor Rashid; Grant A Hill-Cawthorne; Moataz Abd El Ghany
Journal:  Access Microbiol       Date:  2022-04-25

3.  Spatiotemporal Clustering of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Incidence in Saudi Arabia, 2012-2019.

Authors:  Khalid Al-Ahmadi; Sabah Alahmadi; Ali Al-Zahrani
Journal:  Int J Environ Res Public Health       Date:  2019-07-15       Impact factor: 3.390

Review 4.  Infectious Diseases and Mass Gatherings.

Authors:  Van-Thuan Hoang; Philippe Gautret
Journal:  Curr Infect Dis Rep       Date:  2018-08-28       Impact factor: 3.725

5.  "Healthy Hajj 2019" -- what you need to know, before you go.

Authors:  Shahul Hameed Ebrahim; Seydou Doumbia; Habida Elachola; Ziad A Memish
Journal:  Travel Med Infect Dis       Date:  2019-07-11       Impact factor: 6.211

6.  Clinical predictors of mortality of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection: A cohort study.

Authors:  Sarah H Alfaraj; Jaffar A Al-Tawfiq; Ayed Y Assiri; Nojoom A Alzahrani; Amal A Alanazi; Ziad A Memish
Journal:  Travel Med Infect Dis       Date:  2019-03-11       Impact factor: 6.211

7.  Environmental investigation of respiratory pathogens during the Hajj 2016 and 2018.

Authors:  Van-Thuan Hoang; Doudou Sow; Khadidja Belhouchat; Thi-Loi Dao; Tran Duc Anh Ly; Florence Fenollar; Saber Yezli; Badriah Alotaibi; Didier Raoult; Philippe Parola; Vincent Pommier de Santi; Philippe Gautret
Journal:  Travel Med Infect Dis       Date:  2019-10-07       Impact factor: 6.211

8.  MERS: What is the current situation in Saudi Arabia?

Authors:  Ziad A Memish
Journal:  J Travel Med       Date:  2018-01-01       Impact factor: 8.490

Review 9.  Mass gatherings medicine: public health issues arising from mass gathering religious and sporting events.

Authors:  Ziad A Memish; Robert Steffen; Paul White; Osman Dar; Esam I Azhar; Avinash Sharma; Alimuddin Zumla
Journal:  Lancet       Date:  2019-05-18       Impact factor: 79.321

10.  Management of hospitalized drug sensitive pulmonary tuberculosis patients during the Hajj mass gathering: A cross sectional study.

Authors:  Badriah Alotaibi; Kingsley Bieh; Yara Yassin; Abdulaziz Mushi; Fuad Maashi; Amnah Awam; Gamal Mohamed; Amir Hassan; Saber Yezli
Journal:  Travel Med Infect Dis       Date:  2019-07-13       Impact factor: 6.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.